Abstract:Ligand pharmacology of histamine H(3)-receptors is species-dependent. In previous studies, two amino acids in transmembrane domain 3 (TM III) were shown to play a significant role. In this study, we characterized human and rat histamine H(3)-receptors (hH(3)R and rH(3)R, respectively), co-expressed with mammalian G proteins in Sf9 insect cell membranes. We compared a series of imidazole-containing H(3)R ligands in radioligand binding and steady-state GTPase assays. H(3)Rs similarly coupled to Gα(i/o)-proteins. Affinities and potencies of the agonists histamine, N(α)-methylhistamine and R-(α)-methylhistamine were in the same range. Imetit was only a partial agonist. The pharmacology of imetit and proxifan was similar at both species. However, impentamine was more potent and efficacious at rH(3)R. The inverse agonists ciproxifan and thioperamide showed higher potency but lower efficacy at rH(3)R. Clobenpropit was not species-selective. Strikingly, imoproxifan was almost full agonist at hH(3)R, but an inverse agonist at rH(3)R. Imoproxifan was docked into the binding pocket of inactive and active hH(3)R- and rH(3)R-models and molecular dynamic simulations were performed. Imoproxifan bound to hH(3)R and rH(3)R in E-configuration, which represents the trans-isomer of the oxime-moiety as determined in crystallization studies, and stabilized active hH(3)R-, but inactive rH(3)R-conformations. Large differences in electrostatic surfaces between TM III and TM V cause differential orientation of the oxime-moiety of imoproxifan, which then differently interacts with the rotamer toggle switch Trp(6.48) in TM VI. Collectively, the substantial species differences at H(3)Rs are explained at a molecular level by the use of novel H(3)R active-state models.

Identification of a HEK-293 Cell Line Containing Stably-Transfected H3 R Gene and Screening for Novel Non-Imidazole Histamine H3 Receptor Antagonists

Identification And Characterization Of Zel-H16 As A Novel Agonist Of The Histamine H-3 Receptor

Different antagonist binding properties of human and rat histamine H3 receptors

[Construction of HEK293 Cell Lines Expressing Hcyslt₂ Receptor and Its Application in Screening of Antagonists].

Pharmacological characterization of seven human histamine H3 receptor isoforms

Construction of eukaryotic expression vector of rat HAS-3 gene and its effects on chemotaxis]

Comparison of the pharmacological properties of human and rat histamine H(3)-receptors

Label-free cell phenotypic profiling of histamine H4R receptor and discovery of non-competitive H4R antagonist from natural products

Design and synthesis of novel 3-substituted-indole derivatives as selective H3 receptor antagonists and potent free radical scavengers.

Identification of novel Ah receptor agonists using a high-throughput green fluorescent protein-based recombinant cell bioassay.

Functional Identification of the Stable Transfection C5ar Cell Line Molt-4

Agonist-Induced Activation of Histamine H3 Receptor Signals to Extracellular Signal-Regulated Kinases 1 and 2 through PKC-, PLD- and EGFR-dependent Mechanisms.

Identification of N-phenyl-3-methoxy-4-pyridinones As Orally Bioavailable H3 Receptor Antagonists and Β-Amyloid Aggregation Inhibitors for the Treatment of Alzheimer's Disease.

Structural Basis for Recognition of Antihistamine Drug by Human Histamine Receptor

Novel Heterocyclic-Substituted Benzofuran Histamine H-3 Receptor Antagonists: in Vitro Properties, Drug-Likeness, and Behavioral Activity

Identification of higenamine as a novel α1 -adrenergic receptor antagonist.

In vitro characterization of [125I]HY-3-24, a selective ligand for the dopamine D3 receptor

High-throughput Screening of Novel Antagonists on Melanin-Concentrating Hormone Receptor-1

Establishment of a CaCC-based Cell Model and Method for High-throughput Screening of M3 Receptor Drugs

Discovery of 18F Labeled AZD5213 Derivatives as Novel Positron Emission Tomography (PET) Radioligands Targeting Histamine Subtype‐3 Receptor

Synthesis, Potency, and in Vivo Profiles of Quinoline Containing Histamine H3Receptor Inverse Agonists